Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS QUE MODIFICAN LA LIBERACIÓN DEL PRINCIPIO ACTIVO |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 03.04. ANTIVIRALES | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.4.2.2. Non-nucleoside reverse transcriptase inhibitors |
Age or weight restriction:
> 6 weeks |
| PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
| Peru | 6.4.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors | No observations |
| El Salvador - 2019 | ANTIVIRALES DE USO SISTÉMICO | No observations |
| Haiti. National List of Essential Medicines | 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) | No observations |
| Belize. National Drug Formulary | 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors | No observations |
| List | Section | Observation |
|---|---|---|
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 05. ANTIVIRALES DE USO SISTÉMICO | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 06.05. ANTIVIRALES | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: FCO X 240 |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 07.07 ANTIVIRALS | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 7.09.02.02. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 8:18 Antiretroviral Agents | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Anti-Retroviral Treatment Programme | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Anti-Retroviral Treatment Programme | No observations |
| Suriname. NGK-C-011 | 6.12 Antiretrovirals | No observations |
| Suriname. NGK-C-011 | 29.1 Antiretrovirals | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 08.18.08.16 Non-nucleoside Reverse Transcriptase Inhibitors | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.4.2.2. Non-nucleoside reverse transcriptase inhibitors |
Age or weight restriction:
> 6 weeks |
| PAHO Strategic Fund Medicine List | 2.6.1. Antiretrovirals | No observations |
| Peru | 6.4.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors | No observations |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Anti-Retroviral Treatment Programme | No observations |
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 60 TABLETA |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 07.07 ANTIVIRALS | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 05. ANTIVIRALES DE USO SISTÉMICO | No observations |
| El Salvador - 2019 | ANTIVIRALES DE USO SISTÉMICO | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 06.05. ANTIVIRALES | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 7.09.02.02. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 8:18 Antiretroviral Agents | No observations |
| Suriname. NGK-C-011 | 6.12 Antiretrovirals | No observations |
| Suriname. NGK-C-011 | 29.1 Antiretrovirals | No observations |
| Haiti. National List of Essential Medicines | 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 08.18.08.16 Non-nucleoside Reverse Transcriptase Inhibitors | No observations |
| Bahamas. Drug Formulary | 07.03.01. Anti-Retroviral (ARV) Agents | No observations |
| Belize. National Drug Formulary | 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 05.03.02 Non-Nucleoside Reverse Transcriptase Inhibitors Analogues (NNRTIs) | No observations |
| List | Section | Observation |
|---|---|---|
| Haiti. National List of Essential Medicines | 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.4.2.2. Non-nucleoside reverse transcriptase inhibitors |
Age or weight restriction:
> 6 weeks |
| Haiti. National List of Essential Medicines | 06.04.02.02 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) | No observations |